- Home
- YMAB vs OPRT Comparison
YMAB vs OPRT Comparison
Compare YMAB & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- OPRT
- Stock Information
- Founded
- YMAB 2015
- OPRT 2005
- Country
- YMAB United States
- OPRT United States
- Employees
- YMAB N/A
- OPRT N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- OPRT Finance: Consumer Services
- Sector
- YMAB Health Care
- OPRT Finance
- Exchange
- YMAB Nasdaq
- OPRT Nasdaq
- Market Cap
- YMAB 192.4M
- OPRT 221.5M
- IPO Year
- YMAB 2018
- OPRT 2019
- Fundamental
- Price
- YMAB $4.60
- OPRT $6.65
- Analyst Decision
- YMAB Buy
- OPRT Hold
- Analyst Count
- YMAB 11
- OPRT 2
- Target Price
- YMAB $17.55
- OPRT $5.00
- AVG Volume (30 Days)
- YMAB 226.0K
- OPRT 382.7K
- Earning Date
- YMAB 05-13-2025
- OPRT 05-08-2025
- Dividend Yield
- YMAB N/A
- OPRT N/A
- EPS Growth
- YMAB N/A
- OPRT N/A
- EPS
- YMAB N/A
- OPRT N/A
- Revenue
- YMAB $88,658,000.00
- OPRT $746,101,000.00
- Revenue This Year
- YMAB N/A
- OPRT $28.62
- Revenue Next Year
- YMAB $16.03
- OPRT $7.92
- P/E Ratio
- YMAB N/A
- OPRT N/A
- Revenue Growth
- YMAB 4.92
- OPRT N/A
- 52 Week Low
- YMAB $3.55
- OPRT $2.37
- 52 Week High
- YMAB $16.11
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- YMAB 56.43
- OPRT 58.97
- Support Level
- YMAB $3.99
- OPRT $6.11
- Resistance Level
- YMAB $5.00
- OPRT $6.69
- Average True Range (ATR)
- YMAB 0.35
- OPRT 0.41
- MACD
- YMAB 0.10
- OPRT -0.04
- Stochastic Oscillator
- YMAB 70.47
- OPRT 36.73
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.